Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: The DCCT/EDIC study 30-year follow-up

The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group·2016·Diabetes Care

Cited by (712)

Items 501–600 of 712

  1. Update Kardiologie 2020
    Michael Lehrke · 2020 · Der Diabetologe
  2. Navigating the Persistent Burden of Diabetic Kidney Disease in Type 1 Diabetes: A Call for Adjunctive Therapies
    Phoom Narongkiatikhun, Petter Bjornstad · 2024 · Kidney International Reports
  3. Association Between Psychosocial Acuity and Glycemic Control in a Pediatric Type 1 Diabetes Clinic
    Joseph Wardell, Dana K. Albright, Claire Chang, Melissa A. Plegue, Jung Eun Lee, Emily Hirschfeld, Ashley N. Garrity, Joyce M. Lee, Melissa J. DeJonckheere · 2024 · The Science of Diabetes Self-Management and Care
  4. Sleep Health Composite and Diabetes Symptom Burden in Young Adults With Type 1 Diabetes
    Stephanie Alisha Griggs, Bethany L. Armentrout, Christine Horvat Davey, Ronald L. Hickman · 2024 · Western Journal of Nursing Research
  5. Effect of glycemic status on myocardial deformation and microvascular function in uncomplicated pediatric type 1 diabetes mellitus: cardiac magnetic resonance imaging
    Lu Zhang, Shan Huang, Xueming Li, Zhigang Yang, Pengfei Ye, Ran Sun, Huayan Xu, Rong Xu, Meng Zhang, Ying Liu et al. · 2025 · Cardiovascular Diabetology
  6. Transient Increase in Cardiomyocyte Protein O‐GlcNAcylation Enhances Susceptibility to Pressure Overload‐Induced Cardiac Remodeling
    Samuel F. Chang, Chae‐Myeong Ha, Manoja Kumar Brahma, Luke Potter, Mahima S. Reddy, Sayan Bakshi, Kerstin Preuß, Md Saimoon Rahman, Johannes K. Fischer, Caitlin A. Harrell et al. · 2026 · Journal of the American Heart Association
  7. In adults living with type 1 diabetes, additional autoimmune diseases are associated with more chronic complications and depression. A BETTER registry analysis
    Cassandra A.A. Locatelli, Meryem Khadija Talbo, Virginie Messier, Caroline Grou, Maha Lebbar, Erin E. Mulvihill, Anne‐Sophie Brazeau, RÉMI P.R. RABASA-LHORET · 2025 · Diabetes & Metabolism
  8. Comparing the Validity of Three Methods for Identifying Impaired Awareness of Hypoglycemia in Predicting Severe Hypoglycemia in Adults with Type 1 Diabetes Mellitus: The PR-IAH Study
    Naoki Sakane, Ken Kato, Sonyun Hata, Erika Nishimura, Rika Araki, Kunichi Kouyama, Masako Hatao, Yuka Matoba, Yuichi Matsushita, Masayuki Domichi et al. · 2025 · Internal Medicine
  9. Optimizing Type 2 Diabetes Management: The Efficacy and Safety of Gliclazide in Clinical Practice
    Viswanathan Mohan, Brij Mohan Makkar, Banshi Saboo, Arvinda Jagadisha, Manoj S Chawla, Neeta Deshpande, Vipan Kumar Goyal, Rohit Kapoor · 2025 · Journal of Diabetology
  10. Trends and disparities in atherosclerotic cardiovascular disease mortality in the middle-aged and older adults with diabetes mellitus in the United States, 1999-2019
    Ahmed Raza, Manal Kaleem, FNU Kalpina, Eman Alamgir, Manayiel Rehmat, Mateen Ahmad, Faiza Fatima, Aleina Ali Shah, Mustafa M. Turkmani, Ubaid Khan · 2025 · The American Journal of the Medical Sciences
  11. Early Graft Loss in Solitary Pancreas Transplant Recipients Within Eurotransplant Region
    Jacobus W. Mensink, Jacob de Bakker, Marko J.K. Mallat, Milou van Bruchem, Danny van der Helm, Marieke van Meel, Aiko P. J. de Vries, RA Pol, Christian Margreiter, Volkert A.L. Huurman · 2026 · Transplantology
  12. Recommendations for Screening, Risk Stratification, and Targeted Treatment for Diabetic Kidney Disease in the UAE
    Alaaeldin M. Bashier, Mona Al Rukhaimi, Amna Khalifa Alhadari, Dawlat Hussein, Mohamed M. Hassanein, Elamin Abdelgadir, Fauzia Rashid, Moayed Alhelfi, Dileep Naik Kumar, Fakhriya Juma Abdulla Alalawi et al. · 2026 · Journal of Diabetes and Endocrine Practice
  13. Glycemic outcomes with smart MDI system in type 1 diabetes: insights from a 12-Month retrospective study
    Miriam Longo, Maria Ida Maiorino, Rita Matrone, Michela Di Nuzzo, Michela Petrizzo, Paola Caruso, Maria Tomasuolo, Mariangela Caputo, Lorenzo Scappaticcio, Giuseppe Bellastella et al. · 2026 · Endocrine
  14. Real-time continuous glucose monitoring with subcutaneously inserted sensor correlates better than subcutaneously implantable sensor with glycated hemoglobin, glycated albumin and fructosamine
    Sanja Medenica, Roberto Negro, Djordje S. Popovic, Michele Chicone, Eupremio Luigi Greco · 2026 · Minerva Endocrinology
  15. SWIIM study protocol: a pre-post study evaluating the implementation of an established pediatric diabetes management program to improve glycemic outcomes for children and young people with type 1 diabetes
    Christopher M Lawrence, Carmel E. Smart, Megan A. Paterson, John Henry Wiggers, Anthea Bill, Christopher J. Oldmeadow, Bruce R. King · 2026 · Frontiers in Endocrinology
  16. Metabolic memory failure and the reprogramming of atherosclerosis in diabetes
    M. Devi, Evelyn Sharon Sukumaran, N. Harikrishnan, N Pavithra, L. Shakthi · 2026 · Obesity Medicine
  17. An explicative review on Diabetic Cardiac Autonomic Neuropathy: From pathophysiology to the era of gene therapy
    Rudra Chakravarti, Payal Ramesh Bankar, Jhanshi Chigilipalli, Dipanjan Roy, Bireswar Bhattacharya, Aditya Kumar Pradhan, Rashmi Singh, Mansi Arya, Anirban Kundu, Dipanjan Ghosh · 2026 · Vascular Pharmacology
  18. Is diabetes still a state of premature cardiovascular death?
    Miles Fisher · 2016 · Practical Diabetes
  19. Putting the Patient Back in Patient Care: Health Decision-Making from the Patient’s Perspective
    Bill R. Garris, Amy J. Weber · 2018 · The Qualitative Report
  20. Duration of Insulin Supply in Type 1 Diabetes: Are 90 Days Better or Worse Than 30 Days?
    Mary A.M. Rogers, Catherine Kim, Renuka Tipirneni, Tanima Basu, Joyce M. Lee · 2019 · Diabetes Spectrum
  21. Facteurs de risque et maladies chroniques : le diabète en exemple
    Jean-Louis Schlienger, L. Monnier, N. Essekkat, Abdelilah El Azrak, F. Raji, Driss Rochd · 2019 · Médecine des Maladies Métaboliques
  22. Diabetes mellitus Typ 1 bei Kindern und Jugendlichen: Praxis der Insulininjektions- und Pumpentherapie
    Thomas Danne, Ralph Ziegler · 2019 · Springer Reference Medizin
  23. Atherosclerosis in patients with type 1 diabetes
    David Karásek · 2019 · Vnitřní lékařství
  24. Diabetes Mellitus and Chronic Kidney Disease (Stages 1–5)
    Meaghan Elger, Arti Sharma Parpia, Dana Whitham · 2020 · Springer eBooks
  25. Glycaemic control in insulin deficient patients using different insulin delivery and glucose sensoring devices: Cross-sectional real-life study
    Elena Putula, Päivi M. Hannula, Heini Huhtala, Saara Metso · 2022 · Diabetes Epidemiology and Management
  26. Prevalence and factors associated with statin use in high-risk patients with type 1 diabetes from a specialized diabetes unit
    Antonio Jesús Amor, Emilio Ortega, Marga Giménez, Montserrat Cofán, Jesús Blanco, Adriana Pané, Laura Boswell, Irene Vinagre, Enric Esmatjes, Ignacio Conget · 2019 · Endocrinología Diabetes y Nutrición (English ed )
  27. Analysis of Dynamic Association Between Diabetes Mellitus and Cardiovascular Disease
    R.S. Krishan, Kishore Asha, U. Vijay · 2022 · Cardiometry
  28. Interpretación del monitoreo continuo de glucosa: una visión práctica
    Nicolás Coronel-Restrepo, Alex Ramírez Rincón, Andrés Palacio, María Rocío Delgado, José Fernando Botero · 2023 · Revista Colombiana de Endocrinología Diabetes & Metabolismo
  29. Recent Trials on the Cardioprotective Effects of New Generation Anti-diabetic and Lipid-Lowering Agents
    Omar Abdelfattah, Ahmed Sayed, Anas Al-Refaei, Jasmin Abdeldayem, Khaled Moustafa, Nicholas Elias, Yehia Saleh · 2023 · Frontiers in clinical drug research. Diabetes and obesity
  30. Evaluation of the dietary inflammatory index in children and adolescents with type 1 diabetes mellitus and its relationship with nutritional status and metabolic control
    Orlando Carvalho de Sousa Bandeira Filho, Wilza Arantes Ferreira Peres, Renata Ribeiro Spinelli, Beatriz Xavier Peniche, Raquel Nascimento Chanca Silvério, Verônica Medeiros da Costa, Jorge Luiz Luescher, Sandra María Lima Ribeiro, Beatriz Martins Vicente, Letícia Victoria Souza da Cunha et al. · 2023 · Nutrition
  31. Assessment of equations estimating average glucose among patients with diabetic kidney disease before dialysis
    Yi Lu, Xiangyu Wang, Qian Zhang, Yaoming Xue · 2024 · International Journal of Diabetes in Developing Countries
  32. Insulin therapy: a century of continuing progress
    Geremia B. Bolli, Carmine Giuseppe Fanelli, Paola Lucidi, Francesca Porcellati · 2023 · Elsevier eBooks
  33. The impact of full reimbursement of flash glucose monitoring on Czech patients - experience of one diabetes center
    Kateřina Štechová, Radek Kovács, Martina Tuháčková, Martina Salátová, Šárka Malá, Pavlína Piťhová, Dita Pichlerová · 2024 · Kontakt
  34. Markers of chronic low-grade inflammation and serum cytokine levels in patients with type 1 diabetes: associations with time in ranges and glucose variability
    Kamilla R. Mavlianova, Julia F. Semenova, Н. Б. Орлов, Vadim Valer'evich Klimontov · 2024 · Diabetes Mellitus
  35. Preparation, characterization, and determination of the therapeutic effects of copper nanoparticles green-formulated by Pistacia atlantica in diabetes-induced cardiac dysfunction in rat
    Jiayue Lin, Yang Jiang, Xu Zhou, Ting Zhang, Yan Xu · 2024 · Open Chemistry
  36. The diabetes annual review in a postal box: A qualitative study exploring the views of people living with diabetes ( DiaBox ‐Qual)
    Jack Colley, Stephanie F. Hughes, Hajira Dambha‐Miller, Hermione Clare Price · 2024 · Diabetic Medicine
  37. Glycation, Aging, and Low Carbohydrate Diets
    Koji Ebe, Michael Wood, Hiroshi Bando · 2025 · Asploro Journal of Biomedical and Clinical Case Reports
  38. Associations between brown adipose tissue activity, serum lipid profiles, and cardiovascular events: insights from 18F-fluorodeoxyglucose PET/computed tomography analysis
    Kewei Yang, Ruiqiu Zhang, Xiaohui Zhang, Qiaoling Gao, Xiuyu Guo, Lianyu Gu, Han Zhang, Jingfeng Zhang, Jianjun Zheng, Maoqing Jiang · 2025 · Nuclear Medicine Communications
  39. Prediction of cardiovascular events by skin auto-fluorescence: the DIABAGE follow-up study
    Jorys Bueno, Alpha Mamadou Diallo, Stéphane Jaisson, J FONTAINE, Céline Lukas, Romain Barriquand, Géraldine Vitellius, Philippe Gillery, Brigitte Delemer, Sara Barraud · 2025 · Diabetes & Metabolism
  40. Cortisol as a Predictor of Nocturnal Hypoglycemia in Insulin-Treated Diabetes: A Cross-Sectional Study
    Tetsushi Nasu, Eri Tamagawa, Atsuyo Fujita · 2025 · Cureus
  41. Role of Vitamin D in the Pathogenesis of Diabetes
    Nadine E. Palermo, Michael F. Holick · 2016 · Springer eBooks
  42. Sykursýki er áskorun: Tíu ára eftirfylgd eistaklinga með sykursýki
    Hafdís Lilja Guðlaugsdóttir, Hafdís Lilja Guðlaugsdóttir, Árún K. Sigurðardóttir, Árún K. Sigurðardóttir · 2018 · Læknablaðið
  43. Partial Hospitalization: An Intervention for Youth with Poorly Controlled Diabetes Mellitus
    Serife Uysal, Jose Bernardo Quintos, Diane DerMarderosian, Heather A. Chapman, Steven E. Reinert, Priya Hirway, Lisa Swartz Topor · 2019 · Endocrine Practice
  44. Update on Medical Management of Diabetes in Children and Adolescents: Epidemiology and Treatment
    D. Daneman · 2020 · Springer eBooks
  45. Diabetestherapie bei nichtalkoholischer Fettlebererkrankung und Leberzirrhose
    Jörg Bojunga · 2020 · Die Gastroenterologie
  46. Costs and economic impacts of type-1 diabetes from the Dominican patient perspective
    Anthony Gutierrez Martinez, Coral Naomi Vargas Peña, Daniela Crespo Almonte, Nancy Esther Romero Castro, Franklyn Colón-Arias, Sergio Gresse · 2021 · Principles and Practice of Clinical Research Journal
  47. Role of Vitamin D in the Pathogenesis of Diabetes
    Nadine E. Palermo, Michael F. Holick · 2017 · Springer eBooks
  48. Children's and young People's diabetes services: What works well and what doesn't?
    Nicky Helen Kime, Stephen Zwolinsky, Andy Pringle, Fiona Campbell · 2022 · Public Health in Practice
  49. Glycemia control using remote technologies
    Л. А. Суплотова, O. O. Alieva · 2023 · Meditsinskiy sovet = Medical Council
  50. Metabolic control and presence of chronic complications of type 1 diabetes mellitus: 25 years of Poznan prospective study
    Aleksandra Cieluch, Aleksandra Araszkiewicz, Dariusz Naskręt, Agata Grzelka‐Woźniak, Aleksandra A. Uruska, Dorota Zozulińska‐Ziółkiewicz · 2023 · Polskie Archiwum Medycyny Wewnętrznej
  51. Coachable or Uncoachable? A Qualitative Study of A Life Coaching Intervention for Young Adults With Type 1 Diabetes
    Trine Ammentorp Gregersen, Karin Waidtløw, Claus Bogh Juhl-, Jette Ammentorp · 2023 · International Journal of Nursing and Health Care Research
  52. Egészségügyi szakmai irányelv : A diabéteszes láb szindrómában szenvedő cukorbetegek ellátása felnőttkorban (klinikai kép, diagnosztika, terápia, megelőzés)
    J. Róbert Bedros, György Jermendy, Tibor Hídvégi, Zsolt Pécsvárady · 2023 · Diabetologia Hungarica
  53. Early Diagnosis of Type 1 Diabetes – Useful or a Pyrrhic Victory?
    Paolo Pozzilli, Silvia Pieralice · 2021 · Wiley eBooks
  54. Extreme ischaemic heart disease risk in people with type 1 diabetes
    William Guy Herrington, Fiona Bragg · 2017 · Heart
  55. Response to Comment on Harlan. Islet Transplantation for Hypoglycemia Unawareness/Severe Hypoglycemia: Caveat Emptor. Diabetes Care 2016;39:1072–1074
    David M. Harlan · 2017 · Diabetes Care
  56. Macrovascular Disease in Type 1 Diabetes
    John R. Petrie · 2022
  57. Características e perfil metabólico dos pacientes com diabetes mellitus atendidos em um centro de referência de endocrinologia da Secretaria Municipal de Saúde de Ribeirão Preto - SP, em 2012 e 2017
    Gustavo Zanelatto Ferlin · 2022
  58. Morning Engagement of Hepatic Insulin Receptors Improves Afternoon Hepatic Glucose Disposal and Storage
    Hannah L. Waterman, Mary Courtney Moore, Marta S. Smith, Ben Farmer, Kalisha C Yankey, Melanie F. Scott, Dale S. Edgerton, Alan D. Cherrington · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Reducing the Risk of Stroke
    Josephine M. E. Gibson, Stephanie P. Jones · 2019 · Wiley eBooks
  60. Diabetesscreening und Risikocheck über die Autofluoreszenz der Haut
    Ovidiu Alin Stirban · 2016 · Info Diabetologie
  61. Mediterranean diet and glycaemic control in a Mediterranean population with type 1 diabetes: a pilot study
    Alexis Kyriacou, Josie M. M. Evans, Angelos Kyriacou · 2017 · Endocrine Abstracts
  62. DYSLIPIDAEMIA IN TYPE 2 DIABETES MELLITUS PATIENTS
    Uday Subhash Bande, Basavaraj Devendrappa Baligar, Basith Lateef Kardkal, Narendra Shankargouda Hiregoudar · 2017 · Journal of Evidence Based Medicine and Healthcare
  63. Higher fractional use of Continuous Subcutaneous Insulin Infusion (CSII) is associated with less diabetes related complications: Lessons from long term insulin pump users
    Claudio Tubili, Ugo Di Folco, Maria Rosaria Nardone, Flavia Tubili, Ohad Cohen · 2017 · Mediterranean Journal of Nutrition and Metabolism
  64. Hypoglycémies à répétition
    Anne Wojtusciszyn · 2017
  65. Hyperglycemia and Atherosclerosis: Experimental Results in Mice
    Akira Asai · 2017 · Nihon Ika Daigaku Igakkai Zasshi
  66. Diabetestherapie bei Niereninsuffizienz
    Ulrich Dischinger, Martin Faßnacht, AC Koschker · 2018 · Der Diabetologe
  67. Pathogenesis of Microvascular Complications
    Mogher Khamaisi, George Liang King, Kyoungmin Park, Qian Li · 2018 · Endocrinology
  68. Management of Diabetes and/or Hyperglycemia in Acute Coronary Syndrome, Acute Stroke, and Acute Heart Failure
    Miles Fisher · 2018
  69. Glycemic Targets and Prevention of Chronic Complications
    Simona Cernea, Avivit Cahn, Itamar Raz · 2018 · Endocrinology
  70. An Overview on Diabetic Nephropathy
    Kei Fukami, Sho‐ichi Yamagishi · 2018 · Elsevier eBooks
  71. Identificação de fatores epigenéticos associados às complicações crônicas em portadores de diabetes mellitus tipo1
    Daniele Pereira dos Santos Bezerra · 2018
  72. Fall 1: Zielwerte – 20 Jahre, ♂, DM Typ 1
    Stefan Kopf · 2018 · Springer eBooks
  73. Fall 55: Zielwerte – 67 Jahre, ♂, DM Typ 2, periphere arterielle Verschlusskrankheit, nichtproliferative Retinopathie und sensorische Neuropathie
    Chrisitan Kasperk · 2018 · Springer eBooks
  74. Fall 31: Spätschäden – 23 Jahre, ♂, DM Typ 1, beginnende diabetische Retinopathie
    Andreas Fischer, Peter Nawroth · 2018 · Springer eBooks
  75. Fall 12: Spätschäden – 50 Jahre, ♀, DM Typ 1, Übergewicht
    Chrisitan Kasperk · 2018 · Springer eBooks
  76. Fall 11: Spätschäden – 50 Jahre, ♂, DM Typ 1, Frakturheilungsstörung
    Chrisitan Kasperk · 2018 · Springer eBooks
  77. Do we still need to demonstrate the survival benefit of pancreas transplantation?
    Pedro Ventura‐Aguiar, Joana Ferrer, Jordi Rovira, Fritz Diekmann · 2018 · American Journal of Transplantation
  78. What Clinicians Need to Know About the Cardiovascular Effects of the Most Recent Classes of Drugs Used for Type 2 Diabetes
    Richard Ferraro, CAITLIN M. NASS, Ramzi Dudum, Roger Scott Blumenthal, Sudipa Sarkar · 2019 · The American Journal of Medicine
  79. Neue Technologien in der Diabetestherapie
    Georg Serfling, Hannes Kalscheuer, Sebastian Michael Schmid, Hendrik Lehnert · 2019 · Der Internist
  80. Therapie des Diabetes mellitus bei chronischer Nierenerkrankung
    Jörg Bojunga, A. W. Mondorf · 2019 · DMW - Deutsche Medizinische Wochenschrift
  81. Bedeutung der Hyperglykämie für das Risiko von CVD-Ergebnissen bei Typ-1-Diabetes
    Michael Jecht · 2019 · Der Diabetologe
  82. Die neue individuelle antihyperglykämische Therapie bei Typ-2-Diabetes
    Kornelia Konz · 2019 · Info Diabetologie
  83. Degludek: napjaink ideális bázisinzulinja?
    László Gerő · 2019 · Diabetologia Hungarica
  84. Cardiomyopathie du diabétique, dépistage et épidémiologie
    Ariel A. Cohen, Denis Angoulvant · 2019 · Archives of Cardiovascular Diseases Supplements
  85. Endothelial function after pancreas transplantation—A single‐center observational study
    Espen Nordheim, Dag Olav Dahle, Thea Anine Strøm Halden, Kåre I. Birkeland, Anders Åsberg, Anders Hartmann, Rune Horneland, Trond Geir Jenssen · 2020 · Clinical Transplantation
  86. Prediction of HbA1c from Fasting Plasma Glucose: Comparison between Uncontrolled and Controlled Diabetes Mellitus among Adults in a Tertiary Care Hospital of Bangladesh
    Parvin Akter Khanam, Tanjima Begum, Md Morshed Alam Khan, Samira Humaira Habib, A. K. Azad Khan · 2020 · Bangladesh Critical Care Journal
  87. Glycaemic control improves after continuous subcutaneous insulin infusion therapy: results from an Irish regional centre for paediatric type 1 diabetes mellitus
    Khubaib Ahmed, Clodagh S. O’Gorman, Orla M. Neylon, Jean A Saunders, Marguerite Lawler, Anne Quinn, Marry Norris, M Conroy-Kelly, Therese Dunne · 2020 · Irish Journal of Medical Science (1971 -)
  88. New Trends: Time in Range and the Use of Continuous Glucose Monitoring Devices on Glycemic Control
    Karyna Lucena Valença De Souza, Marcela Mascarenhas Braga Rassi, Diana Aristótelis Rocha de Sá, Renata Maksoud Bussuan, Luciana Corrêa de Souza Rodrigues, Alberto Krayyem Arbex · 2021 · European Journal of Medical and Health Sciences
  89. Association between microvascular complications and glycated hemoglobin in patients with diabetes
    Biljana Lakić, Verica Petrović, Kosana Stanetić, Suzana Savić · 2020 · Medicinski pregled
  90. Diagnosis and Management of Pediatric Diseases
    Consolato Maria Sergi · 2019 · MDPI eBooks
  91. Technological devices in treatment of diabetes mellitus
    Cem Onur Kıraç, Süleyman Hilmi İpekçi · 2021 · Journal of Bionic Memory
  92. Biomaterial strategies to treat autoimmunity and unwanted immune responses to drugs and transplanted tissues
    Andrew S. Ishizuka, Geoffrey M. Lynn, Christopher M. Jewell · 2021 · Elsevier eBooks
  93. Integrative Analysis of Key Genes and Signaling Pathways By Bioinformatics in Patients with Type 1 Diabetes Mellitus Combined with Acute Myocardial Infarction
    Zhenfei Ou, Xuejuan Zhang · 2021 · Research Square
  94. Metabolic and cardiovascular risk factors associated with type 1 Diabetes Mellitus in pediatric age
    Mariana Araújo, Cíntia Castro Correia · 2022 · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo
  95. Glycemic Targets and Prevention of Chronic Complications
    Simona Cernea, Avivit Cahn, Itamar Raz · 2018 · Endocrinology
  96. Pathogenesis of Microvascular Complications
    Mogher Khamaisi, George Liang King, Kyoungmin Park, Qian Li · 2018 · Endocrinology
  97. Effectiveness of a new smartphone application on type 1 diabetes control and self-management in times of Covid-19: Prospective comparative study (Preprint)
    Nada Derkaoui, Salma Benyakhlef, Imane Rami, Ouafae Elmehraoui, Hajar Charif, Najoua Messaoudi, Nisrine Bouichrat, Imane Assarrar, Abir Tahri, Salma Derbel et al. · 2022
  98. Pathogenesis of Microvascular Complications
    Mogher Khamaisi, George Liang King, Kyoungmin Park, Qian Li · 2019 · Endocrinology
  99. Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225–2230
    Lauren Marie Quinn, Rasiah Thayakaran, G. Neil Thomas, Krishnarajah Nirantharakumar, Parth Narendran · 2022 · Diabetes Care
  100. The clinical-economic characteristic of current basis-bolus insulin therapy schemes in diabetes mellitus type 1 in adults
    А. С. Колбин, Aleksey A. Kurylev, Yu. Е. Balykina, Maxim A. Proskurin · 2022 · Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice